Mayo Clinic invests in pathology data company
Aignostics, a pathology data company with operations in Berlin and New York, announced a $34 million Series B funding round.
The startup, which uses artificial intelligence models to generate insights from pathology data, said the funding would allow it to develop new products and scale in the United States. The company plans to develop a foundation model for pathology in collaboration with Mayo Clinic, according to a news release.
Related: Top digital health funding: General Catalyst, Tennr, HealthEx
Investor Athos led the funding round. Mayo Clinic and Germany-based public-private venture capital firm High-Tech Gründerfonds participated, among other investors. The company has raised $55 million to date.
How a group of clinicians launched a VC firm
Digital health-focused venture capital firm Scrub Capital publicly launched Tuesday. The firm, which has 650 clinician members, is setting the target for its first fund at $10 million and will invest in digital health and medical device companies. Read more.
Healthcare data company secures $5M
Cornerstone AI, which sells automated software that cleans and prepares data, announced a $5 million funding round.
Venture capital firm Acrew Capital led the round. Existing venture capital firm investors Initiate Ventures and Healthy Ventures participated, along with a syndicate of angel investors.
Cornerstone AI said the capital will allow it to scale more quickly and brings the company’s total raised to $10 million. Its product is geared toward speeding research and healthcare analysis.
Sonara Health raises $2.5M in grant funding
Virtual methadone treatment platform Sonara Health announced $2.5 million in grant funding from the National Institute on Drug Abuse.
The company works with care teams to promote adherence to methadone treatment regimens.
The grant will be used to study the effects of Sonara's program, including treatment retention rates, opioid use and costs to payers and patients.
Sonara has raised $2.9 million in grants and $9.2 million from investors to date, according to CEO Michael Giles.
